Literature DB >> 2423715

Role of calcium ion antagonists of the bladder detrusor muscle: in vitro and in vivo study.

M Hassouna, O Nishizawa, I Miyagawa, A Toguri, M Gotoh, M Elhilali.   

Abstract

Calcium (Ca2+) ions play an important role in the contractility of the detrusor. Most of the neurotransmitters and modulators act on the detrusor through altering the final intracellular concentration of Ca2+. We studied three commonly used Ca2+ antagonists on their effect of detrusor contractility in vitro: verapamil, nifedipine and segontin. All three inhibited the detrusor-induced contraction in a dose-dependent fashion. Verapamil showed noncompetitive inhibition. Segontin showed a competitive inhibition on both phasic and tonic contractions of the detrusor strips. Nifedipine selectively inhibited the phasic contraction noncompetitively but competitively suppressed the tonic contraction. The in vivo application of verapamil on the bladder of rabbits with multiple-sclerosis-like disease showed a significant increase in bladder capacity. The study shows the possibility of the potential use of Ca2+-antagonist to suppress the problem of bladder instability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423715     DOI: 10.1016/s0022-5347(17)46085-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle.

Authors:  Jasmin Katrin Badawi; Heng Li; Sigrun Langbein; Stefan Kamp; Sergio Guzman; Stephan Bross
Journal:  J Comp Physiol B       Date:  2006-01-20       Impact factor: 2.200

2.  Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.

Authors:  Jasmin Katrin Badawi; Heng Li; Sigrun Langbein; Sun-Tscheol Kwon; Stefan Kamp; Stephan Bross
Journal:  Eur J Clin Pharmacol       Date:  2006-04-07       Impact factor: 2.953

Review 3.  Comparative tolerability of drug therapies used to treat incontinence and enuresis.

Authors:  R G Owens; M M Karram
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.